Jazz Pharmaceuticals (JAZZ) Change in Account Payables (2010 - 2026)
Jazz Pharmaceuticals' quarterly Change in Account Payables came in at -$21.4 million in Q1 2026, down 212.04% year-on-year from $19.1 million in Q1 2025, and up 26.14% quarter-over-quarter from -$29.0 million in Q4 2025.
Jazz Pharmaceuticals has reported Change in Account Payables for 17 years, with the latest figure at -$21.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 212.04% year-over-year to -$21.4 million; the trailing twelve-month figure through Mar 2026 stood at -$649000.0 (down 103.48% YoY), and the FY2025 full-year result was $39.9 million, up 298.53% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$21.4 million, up from -$29.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $62.4 million in Q3 2025, with the low at -$29.0 million in Q4 2025.
- Average Change in Account Payables over 5 years is -$190823.5, with a median of -$8.1 million recorded in 2023.
- Year-over-year, Change in Account Payables surged 20493.66% in 2022 and tumbled 1042.52% in 2023.
- Tracing JAZZ's Change in Account Payables over 5 years: stood at -$15.4 million in 2022, then soared by 47.43% to -$8.1 million in 2023, then surged by 61.31% to -$3.1 million in 2024, then slumped by 824.15% to -$29.0 million in 2025, then gained by 26.14% to -$21.4 million in 2026.
- The last three Change in Account Payables figures came in at -$21.4 million (Q1 2026), -$29.0 million (Q4 2025), and $62.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | -21.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.40 Mn |
| Mar 31, 2026 | -21.40 Mn |
| Dec 31, 2025 | -28.97 Mn |
| Dec 31, 2025 | -28.97 Mn |
| Sep 30, 2025 | 62.36 Mn |
| Sep 30, 2025 | 62.36 Mn |
| Jun 30, 2025 | -12.64 Mn |
| Jun 30, 2025 | -12.64 Mn |
| Mar 31, 2025 | 19.10 Mn |
| Mar 31, 2025 | 19.10 Mn |
| Dec 31, 2024 | -3.14 Mn |
| Dec 31, 2024 | -3.14 Mn |
| Sep 30, 2024 | -12.79 Mn |
| Sep 30, 2024 | -12.79 Mn |
| Jun 30, 2024 | 15.45 Mn |
| Jun 30, 2024 | 15.45 Mn |
| Mar 31, 2024 | -19.60 Mn |
| Mar 31, 2024 | -19.60 Mn |
| Dec 31, 2023 | -8.10 Mn |
| Dec 31, 2023 | -8.10 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | -26.82 Mn |
| Jun 30, 2023 | -26.82 Mn |
| Mar 31, 2023 | 34.29 Mn |
| Mar 31, 2023 | 34.29 Mn |
| Dec 31, 2022 | -15.41 Mn |
| Dec 31, 2022 | -15.41 Mn |
| Sep 30, 2022 | 28.96 Mn |
| Sep 30, 2022 | 28.96 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | -27.62 Mn |
| Mar 31, 2022 | -27.62 Mn |
| Dec 31, 2021 | 37.85 Mn |
| Dec 31, 2021 | 37.85 Mn |
| Sep 30, 2021 | -142,000.00 |
| Sep 30, 2021 | -142,000.00 |
| Jun 30, 2021 | -31.98 Mn |
| Jun 30, 2021 | -31.98 Mn |
| Mar 31, 2021 | 51.29 Mn |
| Mar 31, 2021 | 51.29 Mn |
| Dec 31, 2020 | -39.58 Mn |
| Dec 31, 2020 | -39.58 Mn |
| Sep 30, 2020 | 15.38 Mn |
| Sep 30, 2020 | 15.38 Mn |
| Jun 30, 2020 | -14.34 Mn |
| Jun 30, 2020 | -14.34 Mn |
| Mar 31, 2020 | 19.60 Mn |
| Mar 31, 2020 | 19.60 Mn |
| Dec 31, 2019 | -24.33 Mn |
| Dec 31, 2019 | -24.33 Mn |
| Sep 30, 2019 | 43.20 Mn |
| Sep 30, 2019 | 43.20 Mn |
| Jun 30, 2019 | -15.65 Mn |
| Jun 30, 2019 | -15.65 Mn |
| Mar 31, 2019 | 1.55 Mn |
| Mar 31, 2019 | 1.55 Mn |
| Dec 31, 2018 | 6.92 Mn |
| Dec 31, 2018 | 6.92 Mn |
| Sep 30, 2018 | 2.75 Mn |
| Sep 30, 2018 | 2.75 Mn |
| Jun 30, 2018 | -15.77 Mn |
| Jun 30, 2018 | -15.77 Mn |
| Mar 31, 2018 | 23.14 Mn |
| Mar 31, 2018 | 23.14 Mn |
| Dec 31, 2017 | -5.92 Mn |
| Dec 31, 2017 | -5.92 Mn |
| Sep 30, 2017 | 783,000.00 |
| Sep 30, 2017 | 783,000.00 |
| Jun 30, 2017 | -518,000.00 |
| Jun 30, 2017 | -518,000.00 |
| Mar 31, 2017 | 5.87 Mn |
| Mar 31, 2017 | 5.87 Mn |
| Dec 31, 2016 | 4.65 Mn |
| Dec 31, 2016 | 4.65 Mn |
| Sep 30, 2016 | -10.51 Mn |
| Sep 30, 2016 | -10.51 Mn |
| Jun 30, 2016 | -4.44 Mn |
| Jun 30, 2016 | -4.44 Mn |
| Mar 31, 2016 | 10.66 Mn |
| Mar 31, 2016 | 10.66 Mn |
| Dec 31, 2015 | -7.11 Mn |
| Dec 31, 2015 | -7.11 Mn |
| Sep 30, 2015 | 2.70 Mn |
| Sep 30, 2015 | 2.70 Mn |
| Jun 30, 2015 | -1.17 Mn |
| Jun 30, 2015 | -1.17 Mn |
| Mar 31, 2015 | 3.30 Mn |
| Mar 31, 2015 | 3.30 Mn |
| Dec 31, 2014 | -4.10 Mn |
| Dec 31, 2014 | -4.10 Mn |
| Sep 30, 2014 | -2.31 Mn |
| Sep 30, 2014 | -2.31 Mn |
| Jun 30, 2014 | -40.13 Mn |
| Jun 30, 2014 | -40.13 Mn |
| Mar 31, 2014 | 8.58 Mn |
| Mar 31, 2014 | 8.58 Mn |
| Sep 30, 2013 | 6.67 Mn |
| Sep 30, 2013 | 6.67 Mn |
| Jun 30, 2013 | 4.71 Mn |
| Jun 30, 2013 | 4.71 Mn |
| Mar 31, 2013 | 16.16 Mn |
| Mar 31, 2013 | 16.16 Mn |
| Dec 31, 2012 | -4.74 Mn |
| Dec 31, 2012 | -4.74 Mn |
| Sep 30, 2012 | -13.91 Mn |
| Sep 30, 2012 | -13.91 Mn |
| Jun 30, 2012 | 6.71 Mn |
| Jun 30, 2012 | 6.71 Mn |
| Mar 31, 2012 | 4.65 Mn |
| Mar 31, 2012 | 4.65 Mn |
| Dec 31, 2011 | -3.33 Mn |
| Dec 31, 2011 | -3.33 Mn |
| Sep 30, 2011 | 3.80 Mn |
| Sep 30, 2011 | 3.80 Mn |
| Jun 30, 2011 | 1.02 Mn |
| Jun 30, 2011 | 1.02 Mn |
| Mar 31, 2011 | 599,000.00 |
| Mar 31, 2011 | 599,000.00 |
| Dec 31, 2010 | -842,000.00 |
| Dec 31, 2010 | -842,000.00 |
| Sep 30, 2010 | -2.51 Mn |
| Sep 30, 2010 | -2.51 Mn |